Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2022 Jun 1;5(6):e2218512.
doi: 10.1001/jamanetworkopen.2022.18512.

Myocarditis or Pericarditis Following mRNA COVID-19 Vaccination

Eric S Weintraub  1 , Matthew E Oster  1   2 , Nicola P Klein  3
Affiliations
Comment

Myocarditis or Pericarditis Following mRNA COVID-19 Vaccination

Eric S Weintraub et al. JAMA Netw Open. .
No abstract available

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest Disclosures: Dr Klein reported receiving grants from the Centers for Disease Control and Prevention, Pfizer, Merck, GlaxoSmithKline, Sanofi Pasteur, and Protein Science (now Sanofi Pasteur) outside the submitted work. No other disclosures were reported.

Comment on

References

    1. Buchan SA, Seo CY, Johnson C, et al. Epidemiology of myocarditis and pericarditis following mRNA vaccination by vaccine product, schedule, and interdose interval among adolescents and adults in Ontario, Canada. JAMA Netw Open. 2022;5(6):e2218505. doi:10.1001/jamanetworkopen.2022.18505 - DOI - PMC - PubMed
    1. Oster ME, Shay DK, Su JR, et al. Myocarditis cases reported after mRNA-based COVID-19 vaccination in the US from December 2020 to August 2021. JAMA. 2022;327(4):331–340. doi:10.1001/jama.2021.24110 - DOI - PMC - PubMed
    1. Mevorach D, Anis E, Cedar N, et al. Myocarditis after BNT162b2 mRNA vaccine against COVID-19 in Israel. N Engl J Med. 2021;385(23):2140–2149. doi:10.1056/NEJMoa2109730 - DOI - PMC - PubMed
    1. Klein NP, Lewis N, Goddard K, et al. Surveillance for adverse events after COVID-19 mRNA vaccination. JAMA. 2021;326(14):1390–1399. doi:10.1001/jama.2021.15072 - DOI - PMC - PubMed
    1. Wallace M, Moulia D, Blain AE, et al. The Advisory Committee on Immunization Practices’ recommendation for use of Moderna COVID-19 vaccine in adults aged ≥18 years and considerations for extended intervals for administration of primary series doses of mRNA COVID-19 vaccines—United States, February 2022. MMWR Morb Mortal Wkly Rep. 2022;71(11):416–421. doi:10.15585/mmwr.mm7111a4 - DOI - PMC - PubMed

LinkOut - more resources